{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:42:29Z","timestamp":1790649749202,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hereditary hemorrhagic telangiectasia (HHT) is a potentially life-threatening genetic vascular disorder caused by loss-of-function mutations in the genes encoding activin receptor-like kinase 1 (ALK1), endoglin, Smad4 and bone morphogenetic protein 9 (BMP9). Injections of mouse neonates with BMP9\/10 blocking antibodies lead to HHT-like vascular defects in the postnatal retinal angiogenesis model. Mothers and their newborns share the same immunity through the transfer of maternal antibodies during lactation. Here, we investigated whether the transmammary delivery route could improve the ease and consistency of administering anti-BMP9\/10 antibodies in the postnatal retinal angiogenesis model. We found that anti-BMP9\/10 antibodies, when intraperitoneally injected into lactating dams, are efficiently transferred into the blood circulation of lactationally-exposed neonatal pups. Strikingly, pups receiving anti-BMP9\/10 antibodies\n                    <jats:italic>via<\/jats:italic>\n                    lactation displayed consistent and robust vascular pathology in the retina, which included hypervascularization and defects in arteriovenous specification, as well as the presence of multiple and massive arteriovenous malformations. Furthermore, RNA-Seq analyses of neonatal retinas identified an increase in the key pro-angiogenic factor, angiopoietin-2, as the most significant change in gene expression triggered by the transmammary delivery of anti-BMP9\/10 antibodies. Transmammary-delivered BMP9\/10 immunoblocking in the mouse neonatal retina is therefore a practical, noninvasive, reliable and robust model of HHT vascular pathology.\n                  <\/jats:p>","DOI":"10.1038\/srep37366","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T05:46:11Z","timestamp":1479793571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10"],"prefix":"10.1038","volume":"6","author":[{"given":"Santiago","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Chandakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prodyot K.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Papoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Campagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Marambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"BFsrep37366_CR1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJM199510053331407","volume":"333","author":"AE Guttmacher","year":"1995","unstructured":"Guttmacher, A. E., Marchuk, D. A. & White, R. I. Hereditary hemorrhagic telangiectasia. N Engl J Med 333, 918\u2013924, doi: 10.1056\/NEJM199510053331407 (1995).","journal-title":"N Engl J Med"},{"key":"BFsrep37366_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00439-010-0825-4","volume":"128","author":"J Richards-Yutz","year":"2010","unstructured":"Richards-Yutz, J., Grant, K., Chao, E. C., Walther, S. E. & Ganguly, A. Update on molecular diagnosis of hereditary hemorrhagic telangiectasia. Hum Genet 128, 61\u201377, doi: 10.1007\/s00439-010-0825-4 (2010).","journal-title":"Hum Genet"},{"key":"BFsrep37366_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(SICI)1096-8628(19980319)76:3<269::AID-AJMG12>3.0.CO;2-F","volume":"76","author":"DA Marchuk","year":"1998","unstructured":"Marchuk, D. A., Guttmacher, A. E., Penner, J. A. & Ganguly, P. Report on the workshop on Hereditary Hemorrhagic Telangiectasia, July 10\u201311, 1997. Am J Med Genet 76, 269\u2013273 (1998).","journal-title":"Am J Med Genet"},{"key":"BFsrep37366_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10456-015-9482-5","volume":"18","author":"H Arthur","year":"2015","unstructured":"Arthur, H. et al. Executive summary of the 11th HHT international scientific conference. Angiogenesis 18, 511\u2013524, doi: 10.1007\/s10456-015-9482-5 (2015).","journal-title":"Angiogenesis"},{"key":"BFsrep37366_CR5","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/j.1538-7836.2010.03860.x","volume":"8","author":"S Dupuis-Girod","year":"2010","unstructured":"Dupuis-Girod, S., Bailly, S. & Plauchu, H. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost 8, 1447\u20131456, doi: 10.1111\/j.1538-7836.2010.03860.x (2010).","journal-title":"J Thromb Haemost"},{"key":"BFsrep37366_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","volume":"24","author":"CL Shovlin","year":"2010","unstructured":"Shovlin, C. L. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24, 203\u2013219, doi: 10.1016\/j.blre.2010.07.001 (2010).","journal-title":"Blood Rev"},{"key":"BFsrep37366_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister, K. A. et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8, 345\u2013351, doi: 10.1038\/ng1294-345 (1994).","journal-title":"Nat Genet"},{"key":"BFsrep37366_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson, D. W. et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13, 189\u2013195, doi: 10.1038\/ng0696-189 (1996).","journal-title":"Nat Genet"},{"key":"BFsrep37366_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2015.00001","volume":"6","author":"J McDonald","year":"2015","unstructured":"McDonald, J. et al. Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6, 1, doi: 10.3389\/fgene.2015.00001 (2015).","journal-title":"Front Genet"},{"key":"BFsrep37366_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione, C. J. et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363, 852\u2013859, doi: 10.1016\/S0140-6736(04)15732-2 (2004).","journal-title":"Lancet"},{"key":"BFsrep37366_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","volume":"93","author":"WL Wooderchak-Donahue","year":"2013","unstructured":"Wooderchak-Donahue, W. L. et al. BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93, 530\u2013537, doi: 10.1016\/j.ajhg.2013.07.004 (2013).","journal-title":"Am J Hum Genet"},{"key":"BFsrep37366_CR12","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","volume":"109","author":"L David","year":"2007","unstructured":"David, L., Mallet, C., Mazerbourg, S., Feige, J. J. & Bailly, S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109, 1953\u20131961, doi: 10.1182\/blood-2006-07-034124 (2007).","journal-title":"Blood"},{"key":"BFsrep37366_CR13","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1242\/jcs.002949","volume":"120","author":"M Scharpfenecker","year":"2007","unstructured":"Scharpfenecker, M. et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120, 964\u2013972, doi: 10.1242\/jcs.002949 (2007).","journal-title":"J Cell Sci"},{"key":"BFsrep37366_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","volume":"102","author":"L David","year":"2008","unstructured":"David, L. et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102, 914\u2013922, doi: 10.1161\/CIRCRESAHA.107.165530 (2008).","journal-title":"Circ Res"},{"key":"BFsrep37366_CR15","doi-asserted-by":"publisher","first-page":"25111","DOI":"10.1074\/jbc.M503328200","volume":"280","author":"MA Brown","year":"2005","unstructured":"Brown, M. A. et al. Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280, 25111\u201325118, doi: 10.1074\/jbc.M503328200 (2005).","journal-title":"J Biol Chem"},{"key":"BFsrep37366_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1042\/BST20160083","volume":"44","author":"W Li","year":"2016","unstructured":"Li, W., Salmon, R. M., Jiang, H. & Morrell, N. W. Regulation of the ALK1 ligands, BMP9 and BMP10. Biochem Soc Trans 44, 1135\u20131141, doi: 10.1042\/BST20160083 (2016).","journal-title":"Biochem Soc Trans"},{"key":"BFsrep37366_CR17","doi-asserted-by":"publisher","first-page":"11887","DOI":"10.1073\/pnas.1306074110","volume":"110","author":"H Chen","year":"2013","unstructured":"Chen, H. et al. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc Natl Acad Sci USA 110, 11887\u201311892, doi: 10.1073\/pnas.1306074110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep37366_CR18","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1182\/blood-2012-01-407593","volume":"119","author":"N Ricard","year":"2012","unstructured":"Ricard, N. et al. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 119, 6162\u20136171, doi: 10.1182\/blood-2012-01-407593 (2012).","journal-title":"Blood"},{"key":"BFsrep37366_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9, J. TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol 13, 616\u2013630, doi: 10.1038\/nrm3434 (2012).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep37366_CR20","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.febslet.2012.04.030","volume":"586","author":"J Cai","year":"2012","unstructured":"Cai, J., Pardali, E., S\u00e1nchez-Duffhues, G. & ten Dijke, P. BMP signaling in vascular diseases. FEBS Lett 586, 1993\u20132002, doi: 10.1016\/j.febslet.2012.04.030 (2012).","journal-title":"FEBS Lett"},{"key":"BFsrep37366_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fgene.2015.00035","volume":"6","author":"DS Ardelean","year":"2015","unstructured":"Ardelean, D. S. & Letarte, M. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia. Front Genet 6, 35, doi: 10.3389\/fgene.2015.00035 (2015).","journal-title":"Front Genet"},{"key":"BFsrep37366_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cytogfr.2015.12.005","volume":"27","author":"A Garc\u00eda de Vinuesa","year":"2016","unstructured":"Garc\u00eda de Vinuesa, A., Abdelilah-Seyfried, S., Knaus, P., Zwijsen, A. & Bailly, S. BMP signaling in vascular biology and dysfunction. Cytokine Growth Factor Rev 27, 65\u201379, doi: 10.1016\/j.cytogfr.2015.12.005 (2016).","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFsrep37366_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.devcel.2012.02.005","volume":"22","author":"B Larriv\u00e9e","year":"2012","unstructured":"Larriv\u00e9e, B. et al. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell 22, 489\u2013500, doi: 10.1016\/j.devcel.2012.02.005 (2012).","journal-title":"Dev Cell"},{"key":"BFsrep37366_CR24","doi-asserted-by":"publisher","first-page":"e63138","DOI":"10.1371\/journal.pone.0063138","volume":"8","author":"EJ Choi","year":"2013","unstructured":"Choi, E. J. et al. Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2. PLoS One 8, e63138, doi: 10.1371\/journal.pone.0063138 (2013).","journal-title":"PLoS One"},{"key":"BFsrep37366_CR25","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1038\/ncomms8264","volume":"6","author":"IM Aspalter","year":"2015","unstructured":"Aspalter, I. M. et al. Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. Nat Commun 6, 7264, doi: 10.1038\/ncomms8264 (2015).","journal-title":"Nat Commun"},{"key":"BFsrep37366_CR26","doi-asserted-by":"publisher","first-page":"e0132111","DOI":"10.1371\/journal.pone.0132111","volume":"10","author":"F Alaa El Din","year":"2015","unstructured":"Alaa El Din, F. et al. Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia. PLoS One 10, e0132111, doi: 10.1371\/journal.pone.0132111 (2015).","journal-title":"PLoS One"},{"key":"BFsrep37366_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2010-03-276881","volume":"116","author":"N Ricard","year":"2010","unstructured":"Ricard, N. et al. Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations. Blood 116, 1604\u20131612, doi: 10.1182\/blood-2010-03-276881 (2010).","journal-title":"Blood"},{"key":"BFsrep37366_CR28","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/hmg\/ddu531","volume":"24","author":"C Mallet","year":"2015","unstructured":"Mallet, C. et al. Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function. Hum Mol Genet 24, 1142\u20131154, doi: 10.1093\/hmg\/ddu531 (2015).","journal-title":"Hum Mol Genet"},{"key":"BFsrep37366_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fgene.2015.00025","volume":"6","author":"S Tual-Chalot","year":"2015","unstructured":"Tual-Chalot, S., Oh, S. P. & Arthur, H. M. Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges. Front Genet 6, 25, doi: 10.3389\/fgene.2015.00025 (2015).","journal-title":"Front Genet"},{"key":"BFsrep37366_CR30","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1242\/dev.135392","volume":"143","author":"ER Rochon","year":"2016","unstructured":"Rochon, E. R., Menon, P. G. & Roman, B. L. Alk1 controls arterial endothelial cell migration in lumenized vessels. Development 143, 2593\u20132602, doi: 10.1242\/dev.135392 (2016).","journal-title":"Development"},{"key":"BFsrep37366_CR31","doi-asserted-by":"publisher","first-page":"H959","DOI":"10.1152\/ajpheart.01251.2009","volume":"299","author":"JM L\u00f3pez-Novoa","year":"2010","unstructured":"L\u00f3pez-Novoa, J. M. & Bernabeu, C. The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol 299, H959\u2013H974, doi: 10.1152\/ajpheart.01251.2009 (2010).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep37366_CR32","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1167\/iovs.10-5176","volume":"51","author":"A Stahl","year":"2010","unstructured":"Stahl, A. et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 51, 2813\u20132826, doi: 10.1167\/iovs.10-5176 (2010).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep37366_CR33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/nu3040442","volume":"3","author":"WL Hurley","year":"2011","unstructured":"Hurley, W. L. & Theil, P. K. Perspectives on immunoglobulins in colostrum and milk. Nutrients 3, 442\u2013474, doi: 10.3390\/nu3040442 (2011).","journal-title":"Nutrients"},{"key":"BFsrep37366_CR34","doi-asserted-by":"crossref","unstructured":"Baeyens, N. et al. Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia. J Cell Biol, doi: 10.1083\/jcb.201603106 (2016).","DOI":"10.1083\/jcb.201603106"},{"key":"BFsrep37366_CR35","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1172\/JCI39482","volume":"119","author":"SO Park","year":"2009","unstructured":"Park, S. O. et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119, 3487\u20133496, doi: 10.1172\/JCI39482 (2009).","journal-title":"J Clin Invest"},{"key":"BFsrep37366_CR36","first-page":"387","volume":"87","author":"DA Sholl","year":"1953","unstructured":"Sholl, D. A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 87, 387\u2013406 (1953).","journal-title":"J Anat"},{"key":"BFsrep37366_CR37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.yexcr.2013.03.011","volume":"319","author":"L Eklund","year":"2013","unstructured":"Eklund, L. & Saharinen, P. Angiopoietin signaling in the vasculature. Exp Cell Res 319, 1271\u20131280, doi: 10.1016\/j.yexcr.2013.03.011 (2013).","journal-title":"Exp Cell Res"},{"key":"BFsrep37366_CR38","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","volume":"97","author":"SP Oh","year":"2000","unstructured":"Oh, S. P. et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97, 2626\u20132631 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep37366_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10456-013-9383-4","volume":"17","author":"DS Ardelean","year":"2014","unstructured":"Ardelean, D. S. et al. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment. Angiogenesis 17, 129\u2013146, doi: 10.1007\/s10456-013-9383-4 (2014).","journal-title":"Angiogenesis"},{"key":"BFsrep37366_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mvr.2007.05.005","volume":"74","author":"TM Mundel","year":"2007","unstructured":"Mundel, T. M. & Kalluri, R. Type IV collagen-derived angiogenesis inhibitors. Microvasc Res 74, 85\u201389, doi: 10.1016\/j.mvr.2007.05.005 (2007).","journal-title":"Microvasc Res"},{"key":"BFsrep37366_CR41","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38, W214\u2013W220, doi: 10.1093\/nar\/gkq537 (2010).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep37366_CR42","doi-asserted-by":"publisher","first-page":"e98646","DOI":"10.1371\/journal.pone.0098646","volume":"9","author":"S Tual-Chalot","year":"2014","unstructured":"Tual-Chalot, S. et al. Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression. PLoS One 9, e98646, doi: 10.1371\/journal.pone.0098646 (2014).","journal-title":"PLoS One"},{"key":"BFsrep37366_CR43","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/ATVBAHA.114.303984","volume":"34","author":"EM Garrido-Martin","year":"2014","unstructured":"Garrido-Martin, E. M. et al. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models\u2013brief report. Arterioscler Thromb Vasc Biol 34, 2232\u20132236, doi: 10.1161\/ATVBAHA.114.303984 (2014).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep37366_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298\u2013307, doi: 10.1038\/nature10144 (2011).","journal-title":"Nature"},{"key":"BFsrep37366_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/01.WCB.0000107730.66603.51","volume":"24","author":"B Xu","year":"2004","unstructured":"Xu, B. et al. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 24, 237\u2013244, doi: 10.1097\/01.WCB.0000107730.66603.51 (2004).","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFsrep37366_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12975-010-0020-x","volume":"1","author":"Q Hao","year":"2010","unstructured":"Hao, Q. et al. VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice. Transl Stroke Res 1, 197\u2013201, doi: 10.1007\/s12975-010-0020-x (2010).","journal-title":"Transl Stroke Res"},{"key":"BFsrep37366_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10456-014-9436-3","volume":"17","author":"C Han","year":"2014","unstructured":"Han, C. et al. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2. Angiogenesis 17, 823\u2013830, doi: 10.1007\/s10456-014-9436-3 (2014).","journal-title":"Angiogenesis"},{"key":"BFsrep37366_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2500\/ar.2014.5.0091","volume":"5","author":"AB Thompson","year":"2014","unstructured":"Thompson, A. B. et al. Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia. Allergy Rhinol (Providence) 5, 91\u201395, doi: 10.2500\/ar.2014.5.0091 (2014).","journal-title":"Allergy Rhinol (Providence)"},{"key":"BFsrep37366_CR49","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/lary.22501","volume":"122","author":"TT Karnezis","year":"2012","unstructured":"Karnezis, T. T. & Davidson, T. M. Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy. Laryngoscope 122, 495\u2013497, doi: 10.1002\/lary.22501 (2012).","journal-title":"Laryngoscope"},{"key":"BFsrep37366_CR50","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2012.250","volume":"307","author":"S Dupuis-Girod","year":"2012","unstructured":"Dupuis-Girod, S. et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307, 948\u2013955, doi: 10.1001\/jama.2012.250 (2012).","journal-title":"JAMA"},{"key":"BFsrep37366_CR51","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jama.2016.11387","volume":"316","author":"S Dupuis-Girod","year":"2016","unstructured":"Dupuis-Girod, S. et al. Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia: A Randomized Clinical Trial. JAMA 316, 934\u2013942, doi: 10.1001\/jama.2016.11387 (2016).","journal-title":"JAMA"},{"key":"BFsrep37366_CR52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.2016.11724","volume":"316","author":"KJ Whitehead","year":"2016","unstructured":"Whitehead, K. J. et al. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. JAMA 316, 943\u2013951, doi: 10.1001\/jama.2016.11724 (2016).","journal-title":"JAMA"},{"key":"BFsrep37366_CR53","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.109.211037","volume":"106","author":"M Mahmoud","year":"2010","unstructured":"Mahmoud, M. et al. Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 106, 1425\u20131433, doi: 10.1161\/CIRCRESAHA.109.211037 (2010).","journal-title":"Circ Res"},{"key":"BFsrep37366_CR54","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1242\/dev.060467","volume":"138","author":"P Corti","year":"2011","unstructured":"Corti, P. et al. Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development 138, 1573\u20131582, doi: 10.1242\/dev.060467 (2011).","journal-title":"Development"},{"key":"BFsrep37366_CR55","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1242\/dev.095307","volume":"140","author":"DW Laux","year":"2013","unstructured":"Laux, D. W. et al. Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence. Development 140, 3403\u20133412, doi: 10.1242\/dev.095307 (2013).","journal-title":"Development"},{"key":"BFsrep37366_CR56","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/STROKEAHA.111.647024","volume":"43","author":"I Milton","year":"2012","unstructured":"Milton, I. et al. Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations. Stroke 43, 1432\u20131435, doi: 10.1161\/STROKEAHA.111.647024 (2012).","journal-title":"Stroke"},{"key":"BFsrep37366_CR57","doi-asserted-by":"publisher","first-page":"D13","DOI":"10.1016\/j.jacc.2013.10.035","volume":"62","author":"F Soubrier","year":"2013","unstructured":"Soubrier, F. et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 62, D13\u2013D21, doi: 10.1016\/j.jacc.2013.10.035 (2013).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep37366_CR58","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cca.2009.12.023","volume":"411","author":"L Ojeda-Fernandez","year":"2010","unstructured":"Ojeda-Fernandez, L. et al. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT). Clin Chim Acta 411, 494\u2013499, doi: 10.1016\/j.cca.2009.12.023 (2010).","journal-title":"Clin Chim Acta"},{"key":"BFsrep37366_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/nyas.12726","volume":"1347","author":"A Scholz","year":"2015","unstructured":"Scholz, A., Plate, K. H. & Reiss, Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci 1347, 45\u201351, doi: 10.1111\/nyas.12726 (2015).","journal-title":"Ann N Y Acad Sci"},{"key":"BFsrep37366_CR60","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1158\/0008-5472.CAN-12-4697","volume":"73","author":"D Gerald","year":"2013","unstructured":"Gerald, D., Chintharlapalli, S., Augustin, H. G. & Benjamin, L. E. Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy. Cancer Res 73, 1649\u20131657, doi: 10.1158\/0008-5472.CAN-12-4697 (2013).","journal-title":"Cancer Res"},{"key":"BFsrep37366_CR61","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.molmed.2013.02.004","volume":"19","author":"A Fischer","year":"2013","unstructured":"Fischer, A., Zalvide, J., Faurobert, E., Albiges-Rizo, C. & Tournier-Lasserve, E. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med 19, 302\u2013308, doi: 10.1016\/j.molmed.2013.02.004 (2013).","journal-title":"Trends Mol Med"},{"key":"BFsrep37366_CR62","doi-asserted-by":"crossref","unstructured":"Kim, H., Pawlikowska, L., Su, H. & Young, W. L. In Stroke: Pathophysiology, Diagnosis and Management Vol. 6 (eds James C., Grotta et al.) Genetics and Vascular Biology of Angiogenesis and Vascular Malformations ( Chapter 12). Page 149 (Elsevier, 2015).","DOI":"10.1016\/B978-0-323-29544-4.00012-8"},{"key":"BFsrep37366_CR63","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/nprot.2010.113","volume":"5","author":"ME Pitulescu","year":"2010","unstructured":"Pitulescu, M. E., Schmidt, I., Benedito, R. & Adams, R. H. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat Protoc 5, 1518\u20131534, doi: 10.1038\/nprot.2010.113 (2010).","journal-title":"Nat Protoc"},{"key":"BFsrep37366_CR64","doi-asserted-by":"publisher","first-page":"e69666","DOI":"10.1371\/journal.pone.0069666","volume":"8","author":"KC Dorff","year":"2013","unstructured":"Dorff, K. C. et al. GobyWeb: simplified management and analysis of gene expression and DNA methylation sequencing data. PLoS One 8, e69666, doi: 10.1371\/journal.pone.0069666 (2013).","journal-title":"PLoS One"},{"key":"BFsrep37366_CR65","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"GR Abecasis","year":"2010","unstructured":"Abecasis, G. R. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061\u20131073, doi: 10.1038\/nature09534 (2010).","journal-title":"Nature"},{"key":"BFsrep37366_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321, doi: 10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"BFsrep37366_CR67","doi-asserted-by":"publisher","first-page":"e79871","DOI":"10.1371\/journal.pone.0079871","volume":"8","author":"F Campagne","year":"2013","unstructured":"Campagne, F., Dorff, K. C., Chambwe, N., Robinson, J. T. & Mesirov, J. P. Compression of structured high-throughput sequencing data. PLoS One 8, e79871, doi: 10.1371\/journal.pone.0079871 (2013).","journal-title":"PLoS One"},{"key":"BFsrep37366_CR68","doi-asserted-by":"crossref","unstructured":"Campagne, F., Digan, W. E. R. & Simi, M. MetaR: simple, high-level languages for data analysis with the R ecosystem. bioRxiv, 030254 (2015).","DOI":"10.1101\/030254"},{"key":"BFsrep37366_CR69","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 15, R29, doi: 10.1186\/gb-2014-15-2-r29 (2014).","journal-title":"Genome Biol"},{"key":"BFsrep37366_CR70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289\u2013300 (1995).","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"key":"BFsrep37366_CR71","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408, doi: 10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"BFsrep37366_CR72","doi-asserted-by":"publisher","first-page":"C1294","DOI":"10.1152\/ajpcell.00160.2009","volume":"297","author":"PK Chatterjee","year":"2009","unstructured":"Chatterjee, P. K., Al-Abed, Y., Sherry, B. & Metz, C. N. Cholinergic agonists regulate JAK2\/STAT3 signaling to suppress endothelial cell activation. Am J Physiol Cell Physiol 297, C1294\u2013C1306, doi: 10.1152\/ajpcell.00160.2009 (2009).","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFsrep37366_CR73","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1242\/jcs.167270","volume":"128","author":"V Vingtdeux","year":"2015","unstructured":"Vingtdeux, V. et al. CALHM1 ion channel elicits amyloid-\u03b2 clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain. J Cell Sci 128, 2330\u20132338, doi: 10.1242\/jcs.167270 (2015).","journal-title":"J Cell Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep37366","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T07:54:02Z","timestamp":1672818842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep37366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep37366"],"URL":"https:\/\/doi.org\/10.1038\/srep37366","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/084889","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]},"assertion":[{"value":"7 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37366"}}